Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Colesevelam in GLP-1 Secretion
NCT02050074Phase 4Completed
- Sponsor
- Gentofte Hospital
- Start
- Jan 2014
- Primary completion
- Sep 2014
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin, colesevelam in type 2 diabetes mellitus (T2DM), sponsored by Gentofte Hospital. Started Jan 2014; status: completed.
02
Drugs
metformincolesevelam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02050074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02050074.